About Us

About Us

MedScience Research Group, Inc. (MedScience) develops proprietary diagnostic equipment and products directed for use by the primary care physician. The key criteria of such equipment and products is to provide the primary care physician with a broader avenue in which to practice evidence-based medicine where before it may have been necessary to refer the patient to a specialist. MedScience focuses on diagnostic and treatment protocols that lower medical costs to patients and insurance providers while enhancing the revenue for the primary care physician community. MedScience Research Group aims to enhance the quality of life of individuals and populations through research, evidence-based diagnostics, innovative intervention, education, promotion and distribution, while also enhancing the physician practice.

Our mission: AllergiEnd aims to improve the quality of patients’ lives by empowering non-allergist physicians, such as primary care doctors and pediatricians, with the education, knowledge and tools necessary to provide safe, innovative and effective allergy testing and treatment solutions directly to their patients.

Our goal is to help patients feel better while increasing practice revenue for the non-allergist physician.

If you’re like our current physician clients, you’re looking for:

  • A revenue-generating system that helps your patients feel better
  • Customer service that exceeds your expectations
  • Only the finest quality products
  • On-time delivery of product orders
  • Access to expert knowledge
  • Experienced and available technical support
  • Top-notch training for you and your staff
  • Knowledgeable regulatory and compliance support
  • Expert assistance in seamlessly streamlining AllergiEnd into your medical practice

Yet above all else, you demand satisfaction for your patients and value for your money.

According to the World Health Organization, the number of patients worldwide who are suffering from asthma is over 300 million. With rising trends, this number is expected to increase to 400 million by 2025. Patients with asthma and allergic disease have a reduced quality of life. Asthma causes 250,000 deaths annually. In the United States, 23 million people — including 7 million children — suffer from asthma, and the prevalence is increasing. Pediatric asthma alone results in 14 million missed U.S. school days each year, which in turn results in lost work days for parents and lost wages. As allergies and asthma continue to rise, the World Allergy Organization calls for increased training for non-allergist health professionals to become skilled at diagnosing and treating allergies and asthma.

With this data in mind, we set out to find a solution to the growing allergy crisis. The AllergiEnd diagnostic and Allergen Immunotherapy system is designed for the busy non-allergist, in a primary care setting. To keep up with the demand of the increased need for allergy testing and treatment by non-allergists, we removed the complexity and methodical flaws in typical allergy testing to provide a simple, broad spectrum, allergy diagnostic and immunotherapy solution. A solution that provides relief and treatment for patients whose allergies are not life-threatening yet miserable.

To date, this process has created six published patents. Our organization has authored two reference manuals and developed a comprehensive vocational e-learning platform for the busy primary care practitioner. We are currently developing our third publication.

Meet the individuals behind AllergiEnd:

Fredric W. Pullen MD, FACS
Professor, Otolaryngology, Head and Neck Surgery
University of Miami, Miller School of Medicine

Dr. Pullen studied bacteriology at the University of Michigan and received his Doctor of Medicine at the University of Michigan Medical School where he published his first of many peer-reviewed scientific articles, as well as several books. He continued his studies at Harvard Medical School and at the Massachusetts Eye and Ear Infirmary/Massachusetts General Hospital in Boston, in the specialty of Otorhinolaryngology.

Dr. Pullen served in the United States Air Force (USAF) as an ear, nose and throat (ENT) specialist and vice commander of the 7272 USAF Hospital where he obtained the rank of Major. After his service, he returned to academic medicine at the University of Miami, becoming a clinical professor in the Otolaryngology department and a consultant to the Surgeon General of the Air Force. In his private practice, he began treatment of allergic disease with the use of skin testing and oral and subcutaneous immunotherapy.

Dr. Pullen is a currently a Fellow with several leading medical organizations: American College of Surgeons; American Academy of Facial Plastic and Reconstructive Surgery (emeritus); American Academy of Otolaryngology Head and Neck Surgery; and past president of the American Neurotology Society. He is a member of other prestigious and respected medical organizations including the American Laryngological, Rhinological and Otological Society, the American Academy of Otolaryngic Allergy, and the American Medical Association. Dr. Pullen is also a recipient of the Honor Award from the American Academy of Otolaryngology.

Click here to watch Dr. Fred Pullens Webinar about Allergy Diagnostics and Immunotherapy.

Troy Grogan
President, MedScience Research Group
Former Secretariat Head of the Australian Lifestyle Medicine Association

Mr. Grogan was appointed by the Minister of Health and Director General of Health to the Board of Directors of one of Australia’s largest health systems, Central Coast Health NSW (2002) and the merged Northern Sydney Central Coast Health (2006) where he co-chaired the Human Ethics Committee and served as a member of both the Quality Clinical Council and the Internal Audit and Risk Committee. He also chaired numerous medical appointments and credentialing sub-committees throughout the time he served as a member of the board.

Mr. Grogan has worked in health promotion and medical education for over 14 years, advising government and government-run corporations and corporate organizations on medical research, public health initiatives and evidence-based best practices.

From his experience working with physicians and his knowledge of medical innovation and trends, Mr. Grogan saw the growing need for primary care physicians and non-allergist physicians to be able to diagnose and treat allergy patients. He co-developed the AllergiEnd and AllergiEnd allergy testing and treatment models for primary care, which have been directly helping primary care physicians across the United States since 2013.

Marvin Smollar – Co-Founder, Chairman 

Mr. Smollar earned his engineering degree from the University of Illinois at Urbana and his law degree from Georgetown University. He served as a judicial law clerk for Judge Thomas McMillan of the United States District Court for the Northern District of Illinois. He was also a former Patent Examiner at the United States Patent and Trademark Office.

Mr. Smollar formed the joint venture of Kidco, Inc. and Universal Toys, Ltd. and served as president and chief executive officer of the U.S. component. The success of the combined entity led to its being the first Hong Kong based company to be listed on the New York Stock Exchange as Universal International Matchbox, Inc.

In 1986, Mr. Smollar established his own company, Marchon, Inc., with offices in Chicago and Hong Kong, which merged in 1994 with the Amex-listed Empire of Carolina, Inc. He was appointed president of the combined companies.

Elizabeth Magdaleno – Customer Relations Manager

Ms. Magdaleno is an accomplished bi-lingual medical administrator, with experience in medical group administration, medical billing and patient relations. She manages office administrations, physician office relations and customer service, ordering and fulfillment, and technology relating to the company’s customer relations software, learning management system and accounting.

Jesus Davila – Vice President Business Development

Mr. Davila has over 20 years of experience with managed care government programs. In his early career, he participated in the launch and development of Century Health Plans – Medicaid MCO assisting in its growth and eventual acquisition by PCA.  In 2003, he joined WellCare Health Plans where he led their South Florida Medicare Sales organization overseeing the business development of a $500 million dollar market, consisting of over 20,000 affiliated Medicare beneficiaries within Southeast Florida.

In March of 2010, he joined HealthSun’s family-owned Managed Healthcare Partners-MSO and spearheaded the development of their tactical IPA/MSO Medicare/Medicaid risk and business development organization. He oversaw the implementation of internal sales organizations, provider relations and member support units tailored towards the development and support of medical center staff models specializing in the unique needs required for growth, retention and risk management of Medicare beneficiaries. During a four-year span, the organization matured into five medical center staff models consisting of over 3,000 affiliated Medicare beneficiaries.

Meet our pharmacy staff

Total Town Compounding Center has a mission to help keep patients healthy. Joseph Navarra, owner and pharmacist, has over 22 years of compounding experience. He started customized compounding in 1994 to help the growing need for pediatric dosage forms of HIV medication. Our unique range of service then progressively grew to meet the immediate and on-going needs of patients, caregivers and prescribers.

Exclusively a compounding pharmacy, Total Town Compounding Center specializes in meeting specific patient needs. The pharmacy is a member of the Professional Compounding Centers of America (PCCA), the International Academy of Compounding Pharmacist (IACP), and the Pharmacists Society of the State of New York (PSSNY).

Joseph P. Navarra R.Ph., FACA – Head of Pharmacy

Mr. Navarra is the owner of the Town Total Compounding Pharmacy in Melville, NY, a PCAB accredited pharmacy for sterile and non-sterile products specializing in dosage forms individualized for specific patient needs. For over a decade, he managed and controlled investigational compounds used in AIDS clinical trial group studies sponsored by the Division of AIDS for SUNY-Downstate Children’s Hospital, Harlem Hospital, and Kings County Medical Center. His experience in formulating medications for use in clinical trials has grown to include collaborations with NYU’s Dysautonomia Center for Parkinson’s research, Mount Sinai’s Department of Psychiatry, and Montefiore’s Department of Dermatology. He has received advanced training in medication therapy management and pharmacy-based immunization, and is a full fellow of the American College of Apothecaries.

Mr. Navarra plays an active role in local, state and national-level pharmacy organizations. He is the currently on the New York City Pharmacists Society Board. He has held the positions of vice president, president, and chairman in both the Pharmacist Society of the State of New York. He was the past chairman of the Compounding, IV, & Nuclear Pharmacy Academy of New York.  Joseph is a graduate of St. John’s University College of Pharmacy and Allied Health Professions.

Andrew S. Poster, B.S., Pharm.D. – Quality Assurance Officer and Clinical Specialist

Andrew S. Poster received his B.S. in Biology from Long Island University’s C.W. Post Campus in Brookville, NY and his Doctor of Pharmacy from Lake Erie College of Osteopathic Medicine in Bradenton, FL. He graduated Cum Laude with both of his degrees and was amember of both the Beta Beta Beta Biological Honor Society and the Rho Chi Pharmacy Honor Society. Andrew has been practicing pharmacy for over 10 years as a technician, intern, and pharmacist. Andrew keeps involved with many pharmaceutical organizations such as a PSSNY and has advanced training in both USP <795> and <797> non-sterile, and sterile compounding.

As the quality assurance officer, Andrew is responsible for ensuring and enforcing all quality assurance practices including proper maintenance, biological testing, and monitoring of all equipment as well as the sterile compounding room. As a compounding clinical specialist, he formulates and prepares patient prescriptions based on a prescribers’ order, according to USP < 795> and USP <797> standards. He supports our physicians, dentists, and veterinarians, as well as their staff members with help in addressing unique patient needs. He supports our patients with knowledge and information about their medication and assists with instruction on how to properly use their medication.